Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: concerning (1000)

Liver enhanced recovery - patient information

Description: What to expect in the days before and after your liver resection operation and introducing our liver enhanced recovery programme (ERP
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Liver-enhanced-recovery-2257-PIL.pdf

Your personal data and your rights - patient information

Description: As part of your care at University Hospital Southampton we will need to collect information about you. This data is vital
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Your-personal-data-and-your-rights.pdf

Supplier representative procedure

Description: Procurement and supply chain and the commercial development team appreciate the role that companies play to assist the Trust in providing
Url: /Media/UHS-website-2019/Docs/Policies/Supplier-representative-procedure.pdf

Olaparib Tablets

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCERS OLAPARIB (tablets) This regimen may require funding. Regimen • Ovarian Cancer – Olaparib (tablets) Indication • Olaparib in its tablet
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Olaparib-Tablets.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL 21 day Regimen • Ovary-Carboplatin (AUC5)-Paclitaxel (21 day) Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Uterine-Carboplatin (AUC5)-Paclitaxel (21 day) Indicati
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Capecitabine-Cetuximab-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-CETUXIMAB-OXALIPLATIN (21 day) This regimen may require funding Regimen • Colorectal Cancer – Cape
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Cetuximab-Oxaliplatin.pdf

Thyroid Cabozantinib

Description: Chemotherapy Protocol THYROID CANCER Regimen CABOZANTINIB • Thyroid – Cabozantinib (140mg-capsules) Indication • Unresectable, locally advanced or metastatic th
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Thyroid-Cabozantinib.pdf

Abemaciclib-Fulvestrant

Description: Chemotherapy Protocol Breast Cancer Abemaciclib-Fulvestrant Regimen • Breast Cancer – Abemaciclib-Fulvestrant Indication • Abemaciclib in com
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Fulvestrant.pdf

Abemaciclib-Anastrozole

Description: Chemotherapy Protocol Breast Cancer Abemaciclib-Anastrozole Regimen • Breast Cancer – Abemaciclib-Anastrozole Indication • Abemaciclib in com
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Anastrozole.pdf

291 to 300 of 327

Previous … 28 29 30 31 32 … Next